SCHEMBL1801640

SCHEMBL1801640

O=C(C=Cc1cccc(Br)c1)c1ccc(Br)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1B1 Q16678 3/20 0.73
▸ P4HB P07237 2/20 0.69
▸ HSD17B3 P37058 1/20 0.67
▸ PTPN1 P18031 1/20 0.66
▸ ATM Q13315 1/20 0.64
▸ GPR55 Q9Y2T6 1/20 0.64
▸ RELA Q04206 1/20 0.62
▸ ESR1 P03372 1/20 0.61
▸ ESR2 Q92731 1/20 0.61
▸ CYP2D6 P10635 2/20 0.60
▸ MAOA P21397 3/20 0.57
▸ MAOB P27338 3/20 0.57
▸ CA1 P00915 2/20 0.57
▸ CA2 P00918 2/20 0.57
▸ CYP1A1 P04798 1/20 0.57
▸ CYP1A2 P05177 1/20 0.57
▸ CYP3A4 P08684 1/20 0.57
▸ COMT P21964 1/20 0.56
▸ CXCL12 P48061 1/20 0.56
▸ MAPT P10636 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1801639 1.00 CYP1B1 (0.73) CYP1B1P4HBHSD17B3PTPN1ATM
SCHEMBL16939641 0.95 CYP1B1 (0.67) CYP1B1P4HBHSD17B3PTPN1ATM
SCHEMBL13203470 0.93 CYP1B1 (0.77) CYP1B1P4HBHSD17B3PTPN1ATM
SCHEMBL25283293 0.90 ESR1 (0.67) CYP1B1P4HBHSD17B3ATMGPR55
SCHEMBL29406397 0.90 ESR1 (0.67) CYP1B1P4HBHSD17B3ATMGPR55
SCHEMBL31233016 0.90 ESR1 (0.67) CYP1B1P4HBHSD17B3ATMGPR55
SCHEMBL25193875 0.90 ESR1 (0.67) CYP1B1P4HBHSD17B3ATMGPR55
SCHEMBL8735847 0.90 CYP1B1 (0.68) CYP1B1P4HBHSD17B3PTPN1ATM
SCHEMBL5873207 0.90 CYP1B1 (0.68) CYP1B1P4HBHSD17B3PTPN1ATM
SCHEMBL5873205 0.90 CYP1B1 (0.68) CYP1B1P4HBHSD17B3PTPN1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951827-B2 Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2011-05-31 — — US disclosed
US-20060264487-A1 Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles TIDWELL RICHARD R 2006-11-23 — — US disclosed
EP-1719767-A1 Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles The University of North Carolina at Chapel Hill (US) 2006-11-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264487-A1 Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles PFAS, DHPS, DDO CYP1B1 1228/4885P4HB 1304/4885HSD17B3 3930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback